News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,817 Results
Type
Article (2069)
Company Profile (9)
Press Release (39739)
Section
Business (17271)
Career Advice (79)
Deals (2657)
Drug Delivery (5)
Drug Development (4038)
FDA (959)
Job Trends (973)
News (24373)
Policy (1433)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
Academia (100)
Accelerated approval (1)
Allergies (6)
Alliances (2108)
ALS (3)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (7)
Approvals (998)
Artificial intelligence (10)
Autoimmune disease (4)
Bankruptcy (14)
Best Places to Work (738)
BIOSECURE Act (1)
Biosimilars (8)
Biotechnology (8)
Bladder cancer (2)
Brain cancer (3)
Breast cancer (29)
Cancer (200)
Cardiovascular disease (28)
Career advice (67)
CAR-T (9)
Cell therapy (23)
Clinical research (3683)
Collaboration (41)
Compensation (25)
Complete response letters (2)
COVID-19 (94)
CRISPR (3)
C-suite (11)
Cystic fibrosis (6)
Data (316)
Depression (8)
Diabetes (37)
Diagnostics (418)
Digital health (8)
Drug discovery (1)
Drug pricing (5)
Duchenne muscular dystrophy (16)
Earnings (14395)
Events (4497)
Executive appointments (12)
FDA (1209)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (2)
Funding (44)
Gene editing (5)
Generative AI (1)
Gene therapy (19)
GLP-1 (47)
Government (137)
Grass and pollen (1)
Guidances (146)
Healthcare (1073)
HIV (6)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (12)
Immuno-oncology (3)
Indications (6)
Infectious disease (106)
Inflammatory bowel disease (7)
Influenza (7)
Intellectual property (6)
Interviews (6)
IPO (1718)
Job creations (282)
Job search strategy (63)
Labor market (2)
Layoffs (36)
Legal (313)
Liver cancer (5)
Longevity (1)
Lung cancer (31)
Lymphoma (19)
Machine learning (1)
Manufacturing (44)
MASH (5)
Medical device (1070)
Medtech (1076)
Mergers & acquisitions (992)
Metabolic disorders (72)
Multiple sclerosis (6)
Neurodegenerative disease (12)
Neuropsychiatric disorders (7)
Neuroscience (103)
NextGen: Class of 2026 (271)
Non-profit (191)
Now hiring (1)
Obesity (27)
Opinion (3)
Ovarian cancer (4)
Pain (6)
Pancreatic cancer (4)
Parkinson's disease (4)
Patents (10)
Patient recruitment (9)
Peanut (2)
People (1671)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (843)
Phase 2 (1495)
Phase 3 (1539)
Pipeline (657)
Policy (5)
Postmarket research (165)
Preclinical (288)
Press Release (3)
Prostate cancer (11)
Radiopharmaceuticals (14)
Rare diseases (32)
Real estate (308)
Regulatory (1126)
Reports (3)
Research institute (93)
Resumes & cover letters (11)
Rett syndrome (1)
RSV (2)
Schizophrenia (6)
Series A (4)
Series B (1)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (3)
Startups (136)
Supply chain (3)
Tariffs (3)
The Weekly (2)
Vaccines (49)
Venture capital (3)
Weight loss (23)
Women's health (2)
Worklife (1)
Date
Today (2)
Last 7 days (35)
Last 30 days (145)
Last 365 days (1889)
2026 (198)
2025 (1900)
2024 (2170)
2023 (2306)
2022 (2734)
2021 (3208)
2020 (3014)
2019 (2628)
2018 (2047)
2017 (1592)
2016 (1215)
2015 (1732)
2014 (1264)
2013 (7293)
2012 (990)
2011 (978)
2010 (910)
Location
Africa (51)
Alabama (2)
Arizona (18)
Arkansas (1)
Asia (2526)
Australia (332)
California (720)
Canada (154)
China (54)
Colorado (39)
Connecticut (31)
Delaware (27)
Europe (5886)
Florida (124)
Georgia (31)
Idaho (4)
Illinois (57)
India (6)
Indiana (40)
Japan (16)
Kansas (2)
Kentucky (6)
Louisiana (7)
Maine (7)
Maryland (99)
Massachusetts (434)
Michigan (51)
Minnesota (39)
Missouri (6)
Montana (1)
Nebraska (1)
Nevada (6)
New Hampshire (7)
New Jersey (192)
New York (195)
North Carolina (90)
Northern California (341)
Ohio (12)
Oklahoma (4)
Oregon (3)
Pennsylvania (159)
Puerto Rico (2)
Rhode Island (4)
South America (82)
South Carolina (1)
Southern California (319)
Tennessee (6)
Texas (77)
United States (2505)
Utah (17)
Virginia (5)
Washington D.C. (3)
Washington State (63)
Wisconsin (7)
41,817 Results for "140".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
February 3, 2026
·
4 min read
Press Releases
MEDIPOST Inc. Announces $140 Million in Funding to Accelerate Late-Stage Clinical Development
January 9, 2026
·
2 min read
Neuroscience
Epilepsy Biotech Nabs up to $570M in Deal With Italy’s Angelini Plus $140M Fundraising
In addition to a $140 million series D, GRIN Therapeutics has signed a global licensing deal for the epilepsy disorder drug radiprodil worth $50 million upfront.
May 27, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
September 16, 2025
·
12 min read
Press Releases
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 16, 2025
·
12 min read
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
Phase Ib data show Hernexeos can elicit a confirmed objective response rate of 44% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.
August 11, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABA
A
modulators are poised for clinical trials in 2026.
June 18, 2025
·
2 min read
·
Tristan Manalac
Layoffs
After Axing Diabetes Asset, Vertex Lays Off 140 Staff
The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into one.
June 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
August 12, 2025
·
3 min read
Press Releases
Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial
November 10, 2025
·
15 min read
1 of 4,182
Next
